HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Boshoff Selected Research

Neoplasms (Cancer)

6/2007Characterisation of the anti-apoptotic function of survivin-DeltaEx3 during TNFalpha-mediated cell death.
6/2006Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas.
5/2006A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.
5/2000Viral cyclins.
5/2000Early peripheral lymph node involvement of human herpesvirus 8-associated, body cavity-based lymphoma in a human immunodeficiency virus-negative patient.
2/2000Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer.
2/2000Kaposi's sarcoma-associated herpesvirus: from cell biology to pathogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Boshoff Research Topics

Disease

7Neoplasms (Cancer)
06/2007 - 02/2000
3Kaposi Sarcoma (Kaposi's Sarcoma)
05/2006 - 09/2000
2Sexually Transmitted Diseases (Sexually Transmitted Disease)
06/2001 - 09/2000
1Chordoma
06/2006
1Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2006
1Brain Neoplasms (Brain Tumor)
01/2006
1Adenocarcinoma
02/2004
1Neoplasm Metastasis (Metastasis)
02/2004
1Ovarian Neoplasms (Ovarian Cancer)
02/2004
1Osteosarcoma (Osteogenic Sarcoma)
12/2003
1HIV Infections (HIV Infection)
08/2003
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2002
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
04/2001
1Castleman Disease (Castleman's Disease)
04/2001
1Primary Effusion Lymphoma
03/2001
1Hepatitis B
02/2001
1Lymphoma (Lymphomas)
02/2000
1Lethargy
02/2000
1Kidney Neoplasms (Kidney Cancer)
02/2000
1Necrosis
02/2000
1Disease Progression
02/2000
1Melanoma (Melanoma, Malignant)
02/2000
1Peripheral Nervous System Diseases (PNS Diseases)
02/2000
1Breast Neoplasms (Breast Cancer)
02/2000

Drug/Important Bio-Agent (IBA)

6AntibodiesIBA
05/2006 - 09/2000
3Proteins (Proteins, Gene)FDA Link
06/2006 - 02/2000
2Biomarkers (Surrogate Marker)IBA
06/2006 - 02/2004
2Messenger RNA (mRNA)IBA
12/2003 - 02/2000
2Nuclear Antigens (Extractable Nuclear Antigens)IBA
08/2003 - 02/2000
1SurvivinIBA
06/2007
1Transcription Factors (Transcription Factor)IBA
06/2006
1Brachyury protein (Brachyury)IBA
06/2006
1AntigensIBA
05/2006
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2006
1Mammaglobin BIBA
02/2004
1OligonucleotidesIBA
02/2004
1ezrinIBA
12/2003
1Complementary DNA (cDNA)IBA
12/2003
1Immunoglobulin M (IgM)IBA
04/2001
1Interleukin-6 (Interleukin 6)IBA
04/2001
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
04/2001
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2000
1Prednisone (Sone)FDA LinkGeneric
05/2000
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2000
1Vincristine (Oncovin)FDA LinkGeneric
05/2000
1CyclinsIBA
05/2000
1Monoclonal AntibodiesIBA
02/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2000
1Peptides (Polypeptides)IBA
02/2000
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2000
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
02/2000
1Thalidomide (Thalomid)FDA Link
02/2000

Therapy/Procedure

2Therapeutics
06/2007 - 05/2006
1Drug Therapy (Chemotherapy)
06/2007
1Combination Drug Therapy (Combination Chemotherapy)
05/2000